Shanghai ranks third in the world! The Global Financial Technology Center Development Index (2024) was released. It was learned from the 6th Shanghai International Forum on Financial Technology that the Shanghai Financial Technology Industry Alliance released the "Global Financial Technology Center Development Index (2024)", which was released for the second consecutive year. The results of this index show that new york, London, Shanghai, Beijing, Shenzhen, Tokyo, Chicago, Hong Kong, Singapore and San Francisco rank among the top ten in the world. The index is mainly composed of indicators such as the development level, development potential and development environment of financial technology, which intuitively reflects the development of financial technology in different cities around the world in quantitative form. Compared with the previous index, the list of the top ten cities remains unchanged, but the gap between the index scores of cities has further narrowed, showing the increasingly fierce competition in the development of financial technology in major cities around the world. (CBN)Organic fluorides in two underground waters in Tochigi Prefecture, Japan exceeded the standard. On the 13th, local time, it was learned that the government department of Tochigi Prefecture in Japan said on the same day that organic fluorides exceeding Japan's provisional safe range were detected in the underground waters of two wells located in Ghost Nuqiu, Zhengang City. (CCTV News)Hite Bio: Two drugs are planned to be selected for national centralized drug procurement. Hite Bio announced that the company participated in the tenth batch of national centralized drug procurement. According to the selected results released by the joint procurement, roxatidine acetate hydrochloride and pentoxifylline injection for injection of the company are selected for this centralized procurement. These two drugs are suitable for the treatment of upper gastrointestinal bleeding and peripheral arterial diseases respectively. The procurement cycle is from the date of implementation of the selected results to December 31, 2027, during which medical institutions will give priority to the use of selected drugs. The company obtained the Drug Registration Certificate of the above drugs in 2024, but it has not generated sales revenue this year. This election will help to enhance the brand influence of the company and have a positive impact on the company's development.
On the 13th, SSE 50 index futures fell by 2.58%, and the latest main contract positions changed as follows. According to the exchange data, as of December 13th, SSE 50 index futures closed at 2,412, up or down by -2.58%, with a turnover of 53,000 lots. The position data showed that the top 20 seats were clear, and the difference position was 7,398 lots. The total number of contracts of SSE 50 index futures was 91,500 lots, an increase of 25,700 lots over the previous day. The first 20 seats in the contract held 88,200 lots, an increase of 2,257 lots over the previous day. The short positions in the top 20 seats of the contract were 113,700 lots, an increase of 1,701 lots over the previous day. (Sina Futures)CEO of Cloud Whale Intelligence responded to layoffs: In order to optimize the organizational structure, it was streamlined from 1,600 to 1,400. Zhang Junbin, CEO of Cloud Whale Intelligence, recently issued a statement in a circle of friends, responding to previous reports of layoffs: "The company's personnel adjustment is to optimize the organizational structure and improve organizational efficiency." According to Zhang Junbin, the company was downsized from the original 1,600 to 1,400, which was not a large-scale layoff. Previously, a number of insiders and employees of Cloud Whale Intelligence revealed to Sina Technology that the company has recently started a major layoff. This round of layoffs involves a wide range of business departments, including development departments, testing departments, etc., and in groups, some groups directly cut their staff by half, and extreme groups cut their staff by 65%. In addition, the company's 12 director-level leaders, three of whom left in the past year, "is very mobile." (Sina Technology)SHIBOR reported 1.4040% overnight, down by 7.80 basis points. In 7 days, SHIBOR reported 1.7580%, up 12.30 basis points. SHIBOR reported 1.7350% in three months, down by 0.50 basis point.
Wuzhong, Jiangsu; Dobutamine Hydrochloride Injection and Paramivir Injection are planned to win the bid for the national centralized drug procurement. Jiangsu Wuzhong announced that in the national centralized drug procurement, the bid price of Dobutamine Hydrochloride Injection and Paramivir Injection is 3.58 yuan and 7.47 yuan respectively. The procurement cycle of the two products is until December 31, 2027, and they are supplied to Fujian, Anhui, Jilin, Hubei, Beijing, Inner Mongolia and other provinces and cities respectively. Winning the bid will help to expand the sales of related products, improve market share and brand influence, and have a positive impact on the company's future business performance.Today, Shengguang Group bought 170 million yuan and sold 171 million yuan at the daily limit, with a turnover of 6.558 billion yuan and a turnover rate of 3.239%. After-hours data show that the special seats of Shenzhen Stock Connect bought 170 million yuan and sold 171 million yuan.Zhu Xiaohong, the former party secretary of Guizhou Aerospace Hospital, was decided to be arrested. According to the news of "Guizhou Procuratorate" WeChat WeChat official account, the case of Zhu Xiaohong, the former party secretary of Guizhou Aerospace Hospital (director level), was investigated by Zunyi City Supervision Committee and transferred to the procuratorate for review and prosecution. Under the jurisdiction designated by Zunyi Municipal People's Procuratorate, Fenggang County People's Procuratorate will review and prosecute. A few days ago, the Fenggang County People's Procuratorate made an arrest decision on Zhu Xiaohong on suspicion of accepting bribes. The case is being further processed.
Strategy guide
Strategy guide 12-14
Strategy guide 12-14